Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Yervoy/Opdivo (nivolumab/ipilimumab)
pCPA File Number:
20986
Negotiation Status:
Concluded with an LOI
Indication(s):
Metastatic Melanoma
Sponsor/Manufacturer:
Bristol Myers Squibb Canada Inc.
CADTH Project Number:
pCODR 10098
pCPA Engagement Letter Issued:
2018-06-13
Negotiation Process Concluded:
2019-03-20